• locale

  Denmark

• market

  STOCKS

• industry

  Biotechnology

• website

  www.forward-pharma.com

• ipo date

  Oct 15, 2014

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

*Estimate based on analyst consensus